NewcelX Ltd. (NASDAQ:NCEL) IPO

NewcelX Ltd.

IPO

Went public as NLS Pharmaceutics Ltd. Priced at US$4.15 a unit on Jan 28, 2021.

Price
US$4.15 a unit
Units offered
4,819,277 units
Offering size
US$20 million
Underwriters' option
Up to 722,891 more units
Listing
NLSP on the Nasdaq Capital Market
Underwriters
Maxim Group LLC, Brookline Capital Markets · In the order on the cover
Units delivered
On or about Feb 2, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceDec 18, 2019
Filed publiclyFeb 28, 2020
Amended 5 timesNewest Jan 20, 2021
Shares registered with an exchangeJan 28, 2021
Declared effective by the SECJan 28, 2021
Final prospectus, with the priceFeb 1, 2021

From the cover of the final prospectus (424B4) filed Feb 1, 2021